Immunovant Inc. logo

Immunovant Inc.

IMVT | NASDAQ
Chart Builder DCF Calculator
$37.12
-$0.06 (-0.16%)
Sep 22, 2026, 10:23 AM ET · Market open
Fiscal Year
Period Ending
FY 2026
Mar 30, 2026
FY 2025
Mar 30, 2025
FY 2024
Mar 30, 2024
FY 2023
Mar 30, 2023
FY 2022
Mar 30, 2022
FY 2021
Mar 30, 2021
PE Ratio
-8.97 -6.26 -16.81 -9.07 -3.85 -13.15
PEG Ratio
-6.12 -0.14 -1.69 -0.46 -0.22 0.63
PS Ratio
n/a n/a n/a n/a n/a n/a
PB Ratio
5.31 3.66 7.07 5.27 1.29 3.60
P/FCF Ratio
-11.12 -6.88 -20.34 -10.13 -5.68 -16.85
P/OCF Ratio
-11.13 -6.89 -20.38 -10.14 -5.70 -16.89
OCF/S Ratio
n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio
0 0 0 0 0.01 0.01
Quick Ratio
9.09 11.16 13.70 9.34 11.52 21.79
Current Ratio
9.09 11.16 13.70 9.34 11.52 21.79
Asset Turnover
n/a n/a n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a -16.69 n/a n/a
Return on Equity
-59.30% -58.50% -41.98% -58.20% -33.36% -27.44%
Return on Assets
-52.80% -53.31% -38.90% -51.98% -30.40% -26.04%
Return on Invested Capital
-62.46% -61.93% -43.71% -57.26% -33.03% -27.29%
Dividend Yield
n/a n/a n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a n/a n/a
FCF Payout Ratio
n/a n/a n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.